HAMPTON, N.J. (AP) 鈥� HAMPTON, N.J. (AP) 鈥� Celldex Therapeutics Inc. (CLDX) on Thursday reported a loss of $73.5 million in its second quarter.
On a per-share basis, the Hampton, New Jersey-based company said it had a loss of 94 cents.
The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of $1.04 per share.
The biopharmaceutical company posted revenue of $22,000 in the period.
_____
This story was generated by (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a at https://www.zacks.com/ap/CLDX
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
